GSA Capital Partners’s Agios Pharmaceuticals AGIO Stock Holding History

GSA Capital Partners’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$932K	Sell	25,113 -11,359	-31%	-$345K	0.06%	552
2026 Q1	$1.23M	Buy	+36,472	New	+$1.03M	0.08%	370
2025 Q2	–	Sell	-41,029	Closed	-$1.2M	–	1710
2025 Q1	$1.2M	Sell	41,029 -12,200	-23%	-$405K	0.11%	255
2024 Q4	$1.75M	Buy	+53,229	New	+$2.5M	0.13%	123
2024 Q2	–	Sell	-30,853	Closed	-$902K	–	1590
2024 Q1	$902K	Sell	30,853 -73,262	-70%	-$1.96M	0.07%	507
2023 Q4	$2.32M	Buy	+104,115	New	+$2.33M	0.2%	79
2022 Q4	–	Sell	-8,986	Closed	-$254K	–	1413
2022 Q3	$254K	Buy	+8,986	New	+$241K	0.03%	1040
2022 Q1	–	Sell	-58,059	Closed	-$1.91M	–	1370
2021 Q4	$1.91M	Buy	+58,059	New	+$2.34M	0.24%	31
2020 Q4	–	Sell	-17,552	Closed	-$614K	–	1163
2020 Q3	$614K	Buy	+17,552	New	+$769K	0.1%	286
2019 Q4	–	Sell	-11,764	Closed	-$381K	–	1403
2019 Q3	$381K	Buy	11,764 +4,236	+56%	+$175K	0.05%	722
2019 Q2	$375K	Buy	+7,528	New	+$402K	0.04%	847
2018 Q4	–	Sell	-3,400	Closed	-$262K	–	1310
2018 Q3	$262K	Buy	+3,400	New	+$274K	0.01%	1386
2015 Q4	–	Sell	-3,134	Closed	-$221K	–	1788
2015 Q3	$221K	Sell	3,134 -7,600	-71%	-$743K	0.01%	1525
2015 Q2	$1.19M	Sell	10,734 -20,633	-66%	-$2.22M	0.05%	743
2015 Q1	$2.96M	Buy	+31,367	New	+$3.51M	0.12%	170

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

GSA Capital Partners's AGIO Position: Q2 2026 in Review

GSA Capital Partners reduced its Agios Pharmaceuticals (AGIO) stake by 31% in Q2 2026, selling an estimated $345K and leaving 25,113 shares worth $932K. The position accounts for 0.06% of the portfolio, ranked #552.

GSA Capital Partners first reported a position in AGIO in Q1 2015 and has held it in 15 quarters since. The position peaked at $2.96M in Q1 2015. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

GSA Capital Partners held 25,113 shares of Agios Pharmaceuticals worth $932K as of Q2 2026.
GSA Capital Partners sold 11,359 Agios Pharmaceuticals shares in Q2 2026, an estimated $345K.
Agios Pharmaceuticals made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #552 holding.
GSA Capital Partners first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 15 quarters since.
GSA Capital Partners's Agios Pharmaceuticals position peaked at $2.96M in Q1 2015.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.